Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice.

Rejection of bone marrow grafts in irradiated mice is mediated by natural killer (NK) cells and is controlled by genes linked to the major histocompatibility complex (MHC). It has, however, not been possible to identify the genes or their products. An MHC class I (Dd) transgene introduced in C57BL donors prevented the rejection of their bone marrow by NK cells in irradiated allogeneic and F1 hybrid mice expressing the Dd gene. Conversely, H-2Dd transgenic C57BL recipients acquired the ability to reject bone marrow from C57BL donors but not from H-2Dd transgenic C57BL donors. These results provide formal evidence that NK cells are part of a system capable of rejecting cells because they lack normal genes of the host type, in contrast to T cells, which recognize cells that contain abnormal or novel sequences of non-host type.

[1]  W. Seaman,et al.  Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. , 1987, Journal of immunology.

[2]  B. Safai,et al.  HTLV-III in cells cultured from semen of two patients with AIDS. , 1984, Science.

[3]  K. Steimer,et al.  Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features. , 1985, Annals of internal medicine.

[4]  H. Ljunggren,et al.  Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism , 1985, The Journal of experimental medicine.

[5]  W. Murphy,et al.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized , 1987, The Journal of experimental medicine.

[6]  G. Shearer,et al.  Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts , 1977, European journal of immunology.

[7]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[8]  C. Bieberich,et al.  A transgenic class I antigen is recognized as self and functions as a restriction element. , 1987, Journal of immunology.

[9]  I. Nakamura,et al.  Class I H‐2Db determinants are not involved in hybrid resistance to parental H‐2b/Hh‐1b bone marrow allograft , 1987, European journal of immunology.

[10]  M. Bennett,et al.  Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation. , 1987, Journal of immunology.

[11]  H. Wigzell,et al.  In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen , 1988, European journal of immunology.

[12]  C. Bieberich,et al.  Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice , 1988, The Journal of experimental medicine.

[13]  G. Shearer,et al.  Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency. , 1986, Journal of immunology.

[14]  M. Bennett,et al.  PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS , 1971, Journal of Experimental Medicine.

[15]  G. Dennert,et al.  Bone marrow graft rejection as a function of antibody-directed natural killer cells , 1985, The Journal of experimental medicine.

[16]  R. Schooley,et al.  HTLV-III in the semen and blood of a healthy homosexual man. , 1984, Science.